Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-08

Clinical Trial Update: Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery [Phase 1]

View source ↗

Summary

This clinical trial update reports the withdrawal of a Phase 1 pharmacokinetic study of AL-60371 otic suspension in pediatric subjects following tympanostomy tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AL-60371

Snippet

Sponsor: Alcon Research | Conditions: Otitis Media | Phase 1 | Status: WITHDRAWN